And take it only for as long as you need it. If you're younger than 45, you need enough estrogen to protect against long-term health effects. Hormonal hormone therapy may slightly increase the risk of breast cancer. If you have had breast cancer, you will usually be advised not to take HRT.
Combined hormone therapy is associated with a small increase in the risk of heart attack in older women. This risk may be related to age, existing medical conditions, and the time a woman begins receiving hormone therapy. Some research suggests that combination hormone therapy may protect against heart attacks in women who start combination therapy within 10 years of menopause and who are younger than 60. This benefit may be even greater for women who take estrogen alone. Deep vein thrombosis (DVT) Combined hormone therapy and estrogen-only therapy are associated with a small risk of stroke and blood clots from deep vein thrombosis.
This risk increases with age and other factors, such as heart disease, kidney disease, and obesity. Patches, sprays and rings may pose a lower risk than pills taken by mouth. To reduce these symptoms, hormone therapy increases estrogen levels slightly, but not to premenopausal levels. If you decide to take hormone therapy, you and your obstetrician gynecologist should talk every year about whether you should continue with hormone therapy.
Therefore, women who are relatively older or who have passed a long time since menopause (average age, 63.2 years) who participated in the WHI study may not have experienced any significant effect on cardiovascular protection from hormone therapy compared to women in early menopause who have good cardiovascular health. The Preventive Services Working Group advises family doctors and other health professionals to avoid administering hormone replacement therapy to patients for the primary prevention of chronic diseases after menopause. To evaluate ovarian reserve during the menopausal transition, it is possible to measure the serum level of antimullerian hormone (AMH), follicle stimulating hormone (FSH) of the third day, estradiol (E) and the ovarian antral follicle count (AFC) using a pelvic ultrasound, but they are not used as indicators to predict menopause. However, some people may be able to follow hormone therapy for longer, depending on their health status and family medical history. If you're 60 or younger and have hot flashes, night sweats, vaginal dryness, or sleep disturbances, and your last menstrual period was less than 10 years ago, hormone therapy may be right for you.
In addition to reducing symptoms, people who receive hormone therapy often have a better quality of life, better general health, and better bone health when taking the medication for less than five years. The effect of hormone therapy on coronary heart disease may vary depending on the use of progestogen and the timing. when it starts. If you're already taking menopausal hormone therapy, check with your healthcare professional regularly to re-evaluate your need for treatment.
For those who cannot or do not want to use hormonal hormone therapy, there are effective non-hormonal treatments available, allowing each person to find a solution that works for them. The increased risk of stroke due to hormone therapy may be limited to ischemic stroke and has no effect on hemorrhagic stroke. Consequently, hormone therapy does not increase the risk of coronary artery disease in young and healthy menopausal women, but it is not effective if it already have the disease. Because hormone therapy is available in different doses, it's possible to reduce it and see how you feel.
